Vanda Pharmaceuticals | Passivo Circulante



Current Liabilities Alterar Data
Acadia Pharmaceuticals USD 302.53M 92.34M 2025-03
Agios Pharmaceuticals USD 52.37M 28.79M 2025-03
Alnylam Pharmaceuticals USD 1.08B 110.65M 2025-03
Arrowhead Research USD 220.54M 126.78M 2025-03
AstraZeneca USD 29.13B 1.26B 2025-03
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Eli Lilly USD 30.07B 1.69B 2025-03
Halozyme Therapeutics USD 150.38M 11.28M 2025-03
Insmed USD 239.23M 58.29M 2025-03
J&J USD 56.9B 6.58B 2025-03
Ligand Pharmaceuticals USD 58.68M 21.57M 2025-03
Merck USD 25.17B 3.25B 2025-03
Moderna USD 1.6B 602M 2025-03
Novartis USD 28.69B 560M 2024-12
Pfizer USD 36.45B 6.54B 2025-03
PTC Therapeutics USD 595.39M 14.41M 2025-03
Sanofi 32.22B 3.06B 2025-03
Takeda JPY 2.51T 408.56B 2025-03
Teva Pharmaceutical Industries USD 11.16B 1.64B 2025-03
Ultragenyx Pharmaceutical USD 344.15M 59.14M 2024-12
Veracyte USD 75.12M 3.51M 2025-03



Vanda Pharmaceuticals Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.